Cardiovascular risk in chronic kidney disease

Slides:

Advertisements

Similar presentations

Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup

Advertisements

Chronic Kidney Disease in Diabetes

Melody Sherwood, Peter A McCullough The Lancet Global Health

SAVE: Risk of total mortality associated with reduced kidney function

Frederik Persson, Peter Rossing Kidney International Supplements

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

Volume 83, Issue 3, Pages (March 2013)

Management of hypertension in patients with chronic kidney disease

Cardiovascular Disease and CKD: Core Curriculum 2010

Chronic Kidney Disease in Diabetes

Prehypertension and chronic kidney disease: the ox or the plow?

Reassessment of the care of the patient with chronic kidney disease

Progression of renal failure and hypertensive nephrosclerosis

Melody Sherwood, Peter A McCullough The Lancet Global Health

John P. Middleton, Patrick H. Pun Kidney International

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Hypertension management in high risk type II diabetes with CKD: Insights from recent trials with a focus on albuminuria. A case based discussion Matthew.

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Need for better diabetes treatment for improved renal outcome

Volume 72, Issue 10, Pages (November 2007)

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 76, Pages S50-S99 (August 2009)

Volume 70, Pages S21-S25 (December 2006)

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease Johannes F.E. Mann, Qi-Long.

Volume 77, Issue 1, Pages 5-6 (January 2010)

Anemia as a risk factor for chronic kidney disease

Comorbidity and confounding in end-stage renal disease

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing? Gautam R. Shroff, Charles A. Herzog

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

Volume 66, Pages S50-S55 (November 2004)

The epidemiology of chronic kidney disease

Edmund G. Lowrie Kidney International

U-shaped effect of eGFR and mortality

Fructose intake as a risk factor for kidney stone disease

Volume 73, Issue 12, Pages (June 2008)

New insights in uremic toxins

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Proteinuria and hypertensive nephrosclerosis in African Americans

Microbiology and outcomes of peritonitis in North America

Methods for guideline development

Volume 87, Issue 1, Pages (January 2015)

The kidney, a cardiovascular risk marker, and a new target for therapy

The global challenge of chronic kidney disease

Cardiovascular risk factors in chronic kidney disease

Volume 85, Issue 5, Pages (May 2014)

Homocysteine, renal function, and risk of cardiovascular disease

Folkert W. Asselbergs, Hans L. Hillege, Wiek H. Van Gilst

Volume 67, Pages S55-S62 (January 2005)

Cardiovascular risk assessment in kidney transplantation

Cardio-Kidney-Damage: a unifying concept

Organ transplantation goes to the movies

Volume 55, Pages S3-S16 (June 1999)

Volume 80, Issue 10, Pages (November 2011)

Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension Julian Segura, Carlos Campo, Luis M. Ruilope Kidney.

Michael R. Lattanzio, Matthew R. Weir Kidney International

Is it the low-protein diet or simply the salt restriction?

Charles A. Herzog Kidney International

Is complement a target for therapy in renal disease?

Giuseppe Remuzzi, Carlos Chiurchiu, Piero Ruggenenti

Volume 75, Issue 7, Pages (April 2009)

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

Volume 74, Issue 10, Pages (November 2008)

Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease? Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger Kidney.

Sugar-sweetened beverages and chronic disease

Presentation transcript:

Cardiovascular risk in chronic kidney disease Nagesh S. Anavekar, Marc A. Pfeffer Kidney International Volume 66, Pages S11-S15 (November 2004) DOI: 10.1111/j.1523-1755.2004.09203.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Hazard ratio for CV events with declining eGFR in VALIANT. From Anavekar et al, N Engl J Med, 2004. Kidney International 2004 66, S11-S15DOI: (10.1111/j.1523-1755.2004.09203.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Relationship between atherosclerosis and CKD. Kidney International 2004 66, S11-S15DOI: (10.1111/j.1523-1755.2004.09203.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Increasing risk for CV death with worsening albuminuria. From Hillege et al, Circulation, 2002. Kidney International 2004 66, S11-S15DOI: (10.1111/j.1523-1755.2004.09203.x) Copyright © 2004 International Society of Nephrology Terms and Conditions